|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
113,340,000 |
Market
Cap: |
108.83(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.6758 - $2.34 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Karyopharm Therapeutics is a pharmaceutical company focused on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Co.'s main asset, XPOVIO® (selinexor), a Selective Inhibitors of Nuclear Export compound, is indicated for use in adult patients with multiple myeloma who have received at least one prior therapy; adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
41,140 |
41,140 |
Total Buy Value |
$0 |
$0 |
$49,985 |
$49,985 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
924,350 |
1,173,939 |
1,216,699 |
1,560,865 |
Total Sell Value |
$901,474 |
$1,198,663 |
$1,255,793 |
$3,019,031 |
Total People Sold |
4 |
7 |
7 |
8 |
Total Sell Transactions |
8 |
26 |
36 |
61 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shacham Sharon |
President & CSO |
|
2017-12-07 |
4 |
AS |
$10.39 |
$103,903 |
D/D |
(10,000) |
713,510 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2017-12-07 |
4 |
OE |
$0.26 |
$2,640 |
D/D |
10,000 |
723,510 |
|
- |
|
Primiano Christopher Brett |
SVP, OPS, BUS DEV, GC & SEC |
|
2017-11-07 |
4 |
S |
$11.25 |
$55,755 |
D/D |
(4,958) |
21,423 |
|
- |
|
Frenkel Ran |
Chief Dev Operations Officer |
|
2017-11-07 |
4 |
S |
$11.25 |
$55,755 |
D/D |
(4,958) |
24,733 |
|
- |
|
Primiano Christopher Brett |
SVP, OPS, BUS DEV, GC & SEC |
|
2017-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
26,381 |
|
- |
|
Frenkel Ran |
Chief Dev Operations Officer |
|
2017-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
29,691 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2017-10-02 |
4 |
AS |
$12.00 |
$24,000 |
D/D |
(2,000) |
0 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2017-10-02 |
4 |
OE |
$0.26 |
$528 |
D/D |
2,000 |
2,000 |
|
- |
|
Primiano Christopher Brett |
SVP, OPS, BUS DEV, GC & SEC |
|
2017-10-02 |
4 |
AS |
$12.00 |
$18,000 |
D/D |
(1,500) |
11,381 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2017-09-15 |
4 |
AS |
$11.00 |
$31,702 |
D/D |
(2,882) |
0 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2017-09-15 |
4 |
OE |
$0.26 |
$761 |
D/D |
2,882 |
2,882 |
|
- |
|
Primiano Christopher Brett |
SVP, OPS, BUS DEV, GC & SEC |
|
2017-09-15 |
4 |
AS |
$11.00 |
$22,000 |
D/D |
(2,000) |
12,881 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2017-09-11 |
4 |
AS |
$11.00 |
$1,298 |
D/D |
(118) |
0 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2017-09-11 |
4 |
OE |
$0.26 |
$31 |
D/D |
118 |
118 |
|
- |
|
Primiano Christopher Brett |
SVP, OPS, BUS DEV, GC & SEC |
|
2017-08-29 |
4 |
AS |
$10.00 |
$21,950 |
D/D |
(2,195) |
15,686 |
|
- |
|
Primiano Christopher Brett |
SVP, OPS, BUS DEV, GC & SEC |
|
2017-06-26 |
4 |
AS |
$10.03 |
$8,071 |
D/D |
(805) |
14,881 |
|
- |
|
Frenkel Ran |
Chief Dev Operations Officer |
|
2016-11-14 |
4 |
S |
$10.06 |
$33,286 |
D/D |
(3,309) |
14,691 |
|
- |
|
Renz Justin A |
EVP, CFO & Treasurer |
|
2016-11-09 |
4 |
S |
$8.19 |
$35,544 |
D/D |
(4,342) |
19,173 |
|
- |
|
Primiano Christopher Brett |
SVP,CORP DEV,GEN COUNSEL&SEC. |
|
2016-11-09 |
4 |
S |
$8.19 |
$35,544 |
D/D |
(4,342) |
15,819 |
|
- |
|
Primiano Christopher Brett |
SVP,CORP DEV,GEN COUNSEL&SEC. |
|
2016-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
20,161 |
|
- |
|
Renz Justin A |
EVP, CFO & Treasurer |
|
2016-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
23,515 |
|
- |
|
Frenkel Ran |
Chief Dev Operations Officer |
|
2016-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
18,000 |
|
- |
|
Smolokowski Wiaczeslaw |
10% Owner |
|
2016-06-23 |
4 |
S |
$8.03 |
$151,083 |
D/D |
(18,824) |
8,549,920 |
|
- |
|
Smolokowski Wiaczeslaw |
10% Owner |
|
2016-06-13 |
4 |
S |
$8.51 |
$60,214 |
D/D |
(7,074) |
8,568,744 |
|
- |
|
Smolokowski Wiaczeslaw |
10% Owner |
|
2016-06-09 |
4 |
S |
$9.14 |
$274,098 |
D/D |
(30,000) |
8,575,818 |
|
- |
|
592 Records found
|
|
Page 20 of 24 |
|
|